FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 86 filers reported holding FURIEX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.62 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 349,356 | $15,368,000 | 10.66% |
| Consonance Capital Management LP | 761,764 | $33,510,000 | 8.38% |
| Global Alpha Capital Management Ltd. | 66,974 | $3,028,000 | 4.92% |
| Breithorn Capital Management | 59,158 | $2,602,000 | 1.52% |
| Artal Group S.A. | 971,051 | $42,717,000 | 1.39% |
| Montibus Capital Management LLC | 190,286 | $8,370,681,000 | 0.90% |
| THOMPSON SIEGEL & WALMSLEY LLC | 551,606 | $24,265,000 | 0.53% |
| FRANKLIN STREET ADVISORS INC /NC | 43,950 | $1,933,000 | 0.43% |
| AMERICAN CAPITAL MANAGEMENT INC | 49,392 | $2,173,000 | 0.29% |
| Spark Investment Management LLC | 28,200 | $1,240,000 | 0.28% |